1873 - 3161

[1873] Institution:North York General Hospital – [3161] Trial:Phase III Study of Trastuzumab Deruxtecan (T-DXd) with or without Pertuzumab versus Taxane, Trastuzumab and Pertuzumab in HER2-positive, First-line Metastatic Breast Cancer (DESTINY-Breast09)

It seems we can’t find what you’re looking for. Perhaps searching can help.